Local News BBI Faculty Conversations: Dr. Gavin Ha Brotman Baty | February 26, 2021 Today’s installment is with BBI member Dr. Gavin Ha, Assistant Professor, Computational Biology Program in…kchenFebruary 26, 2021 Read More
Local News New Bacterium Named in Honor of Fred Hutch Fred Hutch | February 25, 2021 Fred Hutchinson Cancer Research Center has three Nobel Prizes hanging in its Seattle lobby and a worldwide reputation…kchenFebruary 25, 2021 Read More
Local News Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio Adaptive Biotechnologies | February 25, 2021 Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the…kchenFebruary 25, 2021 Read More
Local News Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for BreyanziTM/Liso-Cel CAR T-Cell Treatment Seattle Cancer Care Alliance | February 24, 2021 Seattle Cancer Care Alliance (SCCA), the only NCCN-designated cancer center in Washington State, has been…kchenFebruary 24, 2021 Read More
Local News Dr. Barbara Jung to Become President of American Gastroenterological Association UW | February 24, 2021 Dr. Barbara Jung, chair of the Department of Medicine, joins the presidential line up for…kchenFebruary 24, 2021 Read More
Local News Vice Provost for Research Dr. Mary Lidstrom Steps Down UW | February 23, 2021 In fall of 2005, Mary Lidstrom was just about to wrap up a nine-year run…kchenFebruary 23, 2021 Read More
Local News NIH Funds Collaborative Effort to Pinpoint the Origins of Duchenne Muscular Dystrophy UW | February 23, 2021 Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease caused by mutations in the…kchenFebruary 23, 2021 Read More
Local News Astellas and Seagen Announce Submission of Two Supplemental Biologics License Applications to the FDA for PADCEV® in Locally Advanced or Metastatic Urothelial Cancer BioSpace | February 22, 2021 Astellas Pharma US (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen, Inc. (Nasdaq:SGEN) today…kchenFebruary 22, 2021 Read More
Local News Notch Therapeutics Raises $85M for Cancer Treatments and Plans to Open Seattle Location GeekWire | February 22, 2021 New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to…kchenFebruary 22, 2021 Read More
Local News Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® in Patients with Previously Treated Advanced Urothelial Cancer Seagen | February 18, 2021 Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…emcguinnFebruary 18, 2021 Read More